Patty Pound

Patty Pound has extensive experience in pharmaceutical marketing, with a focus on strategic planning, branding, and launch strategies.

Patty most recently worked as the Vice President of Marketing at Avadel Pharmaceuticals, a position they have held since March 2022. Prior to that, they served in the same role at Shield Therapeutics plc from November 2020 to March 2022.

From 2019 to 2020, Patty was the Vice President of Marketing at Acasti Pharma Inc. and Acer Therapeutics Inc., where they played a key role in marketing and strategic insights.

Before that, they held various leadership positions, including Senior Director of Marketing at Neurocrine Biosciences from 2018 to 2019, and Senior Director of Marketing at Avanir Pharmaceuticals from 2011 to 2017. At Avanir, they led the launch of multiple products and developed branding and promotional strategies.

Patty also worked as a Strategic Pharmaceutical Marketing Consultant at Blosma, Inc. in 2017, where they provided commercial strategy development and launch planning services for biopharmaceutical clients.

Their earlier career includes roles as the Associate Director of Marketing at Questcor Pharmaceuticals from 2010 to 2011 and the Senior Product Manager at UCB from 2008 to 2010. Patty also served as the Director and Senior Product Manager at Dey, LP from 2002 to 2008, where they were responsible for the re-launch and marketing initiatives of the EpiPen.

Throughout their career, Patty has demonstrated expertise in developing integrated marketing plans, driving brand awareness, and executing successful product launches in the pharmaceutical industry.

Patty Pound attended the University of Missouri Trulaske College of Business from 1987 to 1991. However, no specific degree or field of study is mentioned, so their educational focus and qualifications beyond their time at the university remain unknown.